鞘脂代谢中药物靶点的药物化学方面 - Suppr

Suppr

超能文献

Medicinal chemistry aspects of drug targets in sphingolipid metabolism.

作者信息

Nussbaumer Peter

机构信息

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Brunner Strasse 59, 1235 Vienna, Austria.

出版信息

ChemMedChem. 2008 Apr;3(4):543-51. doi: 10.1002/cmdc.200700252.

DOI:10.1002/cmdc.200700252

PMID:18061920

Abstract

摘要

相似文献

Medicinal chemistry aspects of drug targets in sphingolipid metabolism.鞘脂代谢中药物靶点的药物化学方面

ChemMedChem. 2008 Apr;3(4):543-51. doi: 10.1002/cmdc.200700252.

Sphingolipid metabolizing enzymes as novel therapeutic targets.鞘脂代谢酶作为新型治疗靶点。

Subcell Biochem. 2008;49:487-522. doi: 10.1007/978-1-4020-8831-5_19.

Novel chemotherapeutic drugs in sphingolipid cancer research.鞘脂类癌症研究中的新型化疗药物。

Handb Exp Pharmacol. 2013(215):211-38. doi: 10.1007/978-3-7091-1368-4_12.

Inhibitors of sphingolipid metabolism enzymes.鞘脂代谢酶抑制剂。

Biochim Biophys Acta. 2006 Dec;1758(12):1957-77. doi: 10.1016/j.bbamem.2006.08.017. Epub 2006 Sep 1.

Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).鞘氨醇-1-磷酸代谢抑制剂（鞘氨醇激酶和鞘氨醇-1-磷酸裂解酶）

Chem Phys Lipids. 2016 May;197:69-81. doi: 10.1016/j.chemphyslip.2015.07.007. Epub 2015 Jul 19.

Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.靶向鞘脂代谢的药物：鞘磷脂酶和神经酰胺酶。

Br J Pharmacol. 2011 Jun;163(4):694-712. doi: 10.1111/j.1476-5381.2011.01279.x.

Sphingolipid modulation: a strategy for cancer therapy.鞘脂类调节：癌症治疗的一种策略。

Anticancer Agents Med Chem. 2012 May;12(4):285-302. doi: 10.2174/187152012800228643.

Genetic disorders of simple sphingolipid metabolism.简单鞘脂代谢的遗传性疾病。

Handb Exp Pharmacol. 2013(215):127-52. doi: 10.1007/978-3-7091-1368-4_7.

Sphingolipids and response to chemotherapy.鞘脂与化疗反应

Handb Exp Pharmacol. 2013(216):73-91. doi: 10.1007/978-3-7091-1511-4_4.

Sphingolipid metabolism in the regulation of bioactive molecules.鞘脂代谢在生物活性分子的调节中。

Lipids. 1999;34 Suppl:S5-11. doi: 10.1007/BF02562221.

引用本文的文献

Fragment-Based Hologram QSAR Studies on a Series of 2,4-Dioxopyrimidine-1-Carboxamides As Highly Potent Inhibitors of Acid Ceramidase.基于片段的全息定量构效关系研究：一系列2,4-二氧代嘧啶-1-甲酰胺作为酸性神经酰胺酶的高效抑制剂

Iran J Pharm Res. 2016 Winter;15(Suppl):139-148.

Benzoxazolone carboxamides: potent and systemically active inhibitors of intracellular acid ceramidase.苯并恶唑酮羧酰胺：细胞内酸性神经酰胺酶的强效且具有全身活性的抑制剂。

Angew Chem Int Ed Engl. 2015 Jan 7;54(2):485-9. doi: 10.1002/anie.201409042. Epub 2014 Nov 13.

Sphingosine 1-phosphate lyase inhibition by 2-acetyl-4-(tetrahydroxybutyl)imidazole (THI) under conditions of vitamin B6 deficiency.在维生素B6缺乏的条件下，2-乙酰-4-(四羟基丁基)咪唑(THI)对鞘氨醇-1-磷酸裂解酶的抑制作用

Mol Cell Biochem. 2015 Feb;400(1-2):125-33. doi: 10.1007/s11010-014-2268-z. Epub 2014 Nov 9.

Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer.神秘醇作为治疗前列腺癌的治疗剂的新型合成及生物学评价

ACS Med Chem Lett. 2011 Mar 25;2(6):438-43. doi: 10.1021/ml2000164. eCollection 2011 Jun 9.

Synthesis and characterization of long-chain tartaric acid diamides as novel ceramide-like compounds.长链酒石酸二酰胺的合成与表征作为新型神经酰胺类似物。

Molecules. 2010 Feb 5;15(2):824-33. doi: 10.3390/molecules15020824.

Improved synthesis of a fluorogenic ceramidase substrate.一种荧光法 Ceramidase 底物的改良合成方法。

Bioorg Med Chem. 2010 Feb;18(3):1003-9. doi: 10.1016/j.bmc.2009.12.071. Epub 2010 Jan 6.

Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.鞘氨醇-1-磷酸裂解酶，鞘氨醇-1-磷酸信号传导和功能的关键调节因子。

Adv Enzyme Regul. 2010;50(1):349-62. doi: 10.1016/j.advenzreg.2009.10.024. Epub 2009 Nov 13.

Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency.神经酰胺：二酰甘油的鞘脂类同胞中的支链烷基链可提高生物活性。

Bioorg Med Chem. 2009 Feb 15;17(4):1498-505. doi: 10.1016/j.bmc.2009.01.005. Epub 2009 Jan 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验